Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy
Study of Glyceryl Trierucate and Glyceryl Trioleate (Lorenzo's Oil) Therapy in Male Children With Adrenoleukodystrophy
Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Terminated
No funding, move to expanded access
Other terminated trials from Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- Acquired Brain Injury · Phase NA · Jan 2024
- Spinal Cord Injury · Phase PHASE1/PHASE2 · Jan 2021
- Spinal Cord Injury · Phase NA · Mar 2018
- Becker Muscular Dystrophy · Phase PHASE2 · Jan 2014
- Spinal Cord Injury · Phase PHASE2/PHASE3 · Aug 2013
More terminations from Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Listed as NCT00004418, this PHASE2 trial focuses on Adrenoleukodystrophy and remains terminated or withdrawn. Sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, Inc., it has been updated 9 times since 1998, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2022 [monthly]
Terminated PHASE2
▶ Show 4 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE2
Status: Suspended → Terminated · Phase: PHASE2_PHASE3 → PHASE2
-
Jun 2018 — Nov 2020 [monthly]
Suspended PHASE2_PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Suspended PHASE2_PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Suspended PHASE2_PHASE3
First recorded
Apr 1998
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .